Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
The constantly growing contribution of depressive disorders to the global disease statistics calls for a growth of treatment effectiveness and optimization. Antidepressants are the most frequently prescribed medicines for depressive disorders. However, development of a standardized pharmacotherapeut...
Saved in:
| Main Authors: | L. K. Khokhlov, N. E. Lukyanov |
|---|---|
| Format: | article |
| Language: | RU |
| Published: |
Scientific Сentre for Family Health and Human Reproduction Problems
2019
|
| Subjects: | |
| Online Access: | https://doaj.org/article/ef2a9816e819456a8e250423b72feaf5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program
by: Michelle Liu, et al.
Published: (2021) -
Pharmacogenetics
Published: (1991) -
Effect of Pharmacogenetic-Based Decision Support Tools in Improving Depression Outcomes: A Systematic Review
by: Aboelbaha S, et al.
Published: (2021) -
Mind your state: Insights into antidepressant nonadherence
by: De Wet Wolmarans, et al.
Published: (2016) -
Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
by: Xandra García-González, et al.
Published: (2021)